## **Core Concept**
Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, is a genetic disorder characterized by **recurrent epistaxis**, mucocutaneous telangiectasias, and visceral arteriovenous malformations. The condition leads to recurrent and often severe nosebleeds due to the presence of fragile blood vessels.

## **Why the Correct Answer is Right**
The treatment of choice for recurrent epistaxis in a patient with HHT often involves **septal dermoplasty** or **septal sclerotherapy**, but among the given options, one would expect a procedure or intervention directly addressing the recurrent and severe nature of epistaxis in HHT. Given that HHT leads to significant morbidity due to recurrent bleeding, treatments aim to reduce the frequency and severity of epistaxis. **Septal dermoplasty** involves covering the nasal septum with a skin graft to prevent direct contact between the nasal mucosa and the airflow, reducing crusting and recurrent bleeding.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is blank and cannot be evaluated.
- **Option B:** Similarly, this option is blank and does not provide a viable alternative for treating recurrent epistaxis in HHT.
- **Option C:** This option is also blank and lacks a treatment strategy for the condition in question.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl for HHT is that patients often require **multidisciplinary care**, including otolaryngology for epistaxis management, to address the various manifestations of the disease. Additionally, recognizing the genetic nature of HHT allows for family screening and early intervention.

## **Correct Answer:** .